Compare ZLAB & ESTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | ESTA |
|---|---|---|
| Founded | 2013 | 2004 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2017 | 2018 |
| Metric | ZLAB | ESTA |
|---|---|---|
| Price | $19.77 | $87.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $49.60 | ★ $86.86 |
| AVG Volume (30 Days) | ★ 888.8K | 787.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.46 | ★ 42.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $460,156,000.00 | $61,208,000.00 |
| Revenue This Year | $9.75 | $28.05 |
| Revenue Next Year | $26.03 | $26.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 15.33 | ★ 76.49 |
| 52 Week Low | $15.96 | $33.35 |
| 52 Week High | $41.20 | $92.84 |
| Indicator | ZLAB | ESTA |
|---|---|---|
| Relative Strength Index (RSI) | 62.65 | 59.22 |
| Support Level | $19.51 | $63.71 |
| Resistance Level | $20.25 | N/A |
| Average True Range (ATR) | 0.75 | 3.93 |
| MACD | 0.24 | -0.19 |
| Stochastic Oscillator | 99.24 | 60.60 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.